The average one-year price target for Jade Biosciences (NasdaqCM:JBIO) has been revised to $19.38 / share. This is an increase of 13.43% from the prior estimate of $17.08 dated September 27, 2025. The ...
The latest price target for Jade Biosciences (NASDAQ:JBIO) was reported by Clear Street on November 25, 2025. The analyst firm set a price target for $25.00 expecting JBIO to rise to within 12 months ...
Jade Biosciences, Inc. operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases. The company develops JADE101 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results